Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Markowitz

Showing results (291-300 of 583) with videos related to

Pageof 59
Sort By:
Vaccine|March 12, 2023
Updated estimate of the annual direct medical cost of screening and treatment for human papillomavirus associated disease in the United StatesPatrick A Clay, Trevor D Thompson, Lauri E Markowitz, et al.
Human Vaccines & Immunotherapeutics|February 19, 2024
High impact of quadrivalent human papillomavirus vaccine across racial/ethnic groups: National Health and Nutrition Examination Survey, 2003-2006 and 2015-2018Ruth Stefanos, Rayleen M Lewis, Troy D Querec, et al.
The Journal of Infectious Diseases|February 8, 2017
Prevalence of Genital Human Papillomavirus in Males, United States, 2013-2014Julia W Gargano, Elizabeth R Unger, Gui Liu, et al.
Vaccine|November 1, 1994
Immunogenicity of high-titre AIK-C or Edmonston-Zagreb vaccines in 3.5-month-old infants, and of medium- or high-titre Edmonston-Zagreb vaccine in 6-month-old infants, in Kinshasa, ZaireF T Cutts, B Nyandu, L E Markowitz, et al.
Pharmacoepidemiology and Drug Safety|May 4, 2011
Exposure to CYP3A4-inducing and CYP3A4-non-inducing antiepileptic agents and the risk of fracturesHedi Schelleman, John R Pollard, Craig Newcomb, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 19, 2021
An Evaluation of Dose-Related HPV Vaccine Effectiveness Using Central Registries in MichiganJulia W Gargano, Mei You, Rachel Potter, et al.
Journal of Clinical Microbiology|July 1, 1991
Evaluation of monoclonal antibody-based capture enzyme immunoassays for detection of specific antibodies to measles virusD D Erdman, L J Anderson, D R Adams, et al.
Sexually Transmitted Infections|January 6, 2001
Willingness to participate in HIV-1 vaccine trials among young Thai menR A Jenkins, K Torugsa, L E Markowitz, et al.
Sexually Transmitted Diseases|June 23, 2025
Association between high-risk HPV prevalence and circumcision status among sexually experienced adult males, 2013-2016, United StatesRayleen M Lewis, Sarah K Brewer, Julia W Gargano, et al.
Annals of Internal Medicine|May 16, 2022
Human Papillomavirus Vaccine Impact and Effectiveness Through 12 Years After Vaccine Introduction in the United States, 2003 to 2018Hannah G Rosenblum, Rayleen M Lewis, Julia W Gargano, et al.
Pageof 59

Showing results (291-300 of 583) with videos related to

Sort By:
Pageof 59
Vaccine|March 12, 2023
Updated estimate of the annual direct medical cost of screening and treatment for human papillomavirus associated disease in the United StatesPatrick A Clay, Trevor D Thompson, Lauri E Markowitz, et al.
Human Vaccines & Immunotherapeutics|February 19, 2024
High impact of quadrivalent human papillomavirus vaccine across racial/ethnic groups: National Health and Nutrition Examination Survey, 2003-2006 and 2015-2018Ruth Stefanos, Rayleen M Lewis, Troy D Querec, et al.
The Journal of Infectious Diseases|February 8, 2017
Prevalence of Genital Human Papillomavirus in Males, United States, 2013-2014Julia W Gargano, Elizabeth R Unger, Gui Liu, et al.
Vaccine|November 1, 1994
Immunogenicity of high-titre AIK-C or Edmonston-Zagreb vaccines in 3.5-month-old infants, and of medium- or high-titre Edmonston-Zagreb vaccine in 6-month-old infants, in Kinshasa, ZaireF T Cutts, B Nyandu, L E Markowitz, et al.
Pharmacoepidemiology and Drug Safety|May 4, 2011
Exposure to CYP3A4-inducing and CYP3A4-non-inducing antiepileptic agents and the risk of fracturesHedi Schelleman, John R Pollard, Craig Newcomb, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 19, 2021
An Evaluation of Dose-Related HPV Vaccine Effectiveness Using Central Registries in MichiganJulia W Gargano, Mei You, Rachel Potter, et al.
Journal of Clinical Microbiology|July 1, 1991
Evaluation of monoclonal antibody-based capture enzyme immunoassays for detection of specific antibodies to measles virusD D Erdman, L J Anderson, D R Adams, et al.
Sexually Transmitted Infections|January 6, 2001
Willingness to participate in HIV-1 vaccine trials among young Thai menR A Jenkins, K Torugsa, L E Markowitz, et al.
Sexually Transmitted Diseases|June 23, 2025
Association between high-risk HPV prevalence and circumcision status among sexually experienced adult males, 2013-2016, United StatesRayleen M Lewis, Sarah K Brewer, Julia W Gargano, et al.
Annals of Internal Medicine|May 16, 2022
Human Papillomavirus Vaccine Impact and Effectiveness Through 12 Years After Vaccine Introduction in the United States, 2003 to 2018Hannah G Rosenblum, Rayleen M Lewis, Julia W Gargano, et al.
Pageof 59